Tricida Inc (TCDA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: TCDA Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-04-28 2022-04-28 S Sale

Isern Brian M.

possible member of 10% group

Major owner
3,895 -0.2%
10.61
41,326 USD 		3,895 -0.2% 10.61 41,326 USD
2022-04-28 2022-04-28 S Sale

Isern Brian M.

possible member of 10% group

Major owner
6,138 -0.2%
10.61
65,124 USD 		6,138 -0.2% 10.61 65,124 USD
2022-04-28 2022-04-28 S Sale

Isern Brian M.

possible member of 10% group

Major owner
1,771 -0.2%
10.61
18,790 USD 		1,771 -0.2% 10.61 18,790 USD
2022-04-28 2022-04-27 S Sale

Isern Brian M.

possible member of 10% group

Major owner
11,078 -0.6%
10.97
121,526 USD 		11,078 -0.6% 10.97 121,526 USD
2022-04-28 2022-04-27 S Sale

Isern Brian M.

possible member of 10% group

Major owner
17,456 -0.6%
10.97
191,492 USD 		17,456 -0.6% 10.97 191,492 USD
2022-04-28 2022-04-27 S Sale

Isern Brian M.

possible member of 10% group

Major owner
5,035 -0.6%
10.97
55,234 USD 		5,035 -0.6% 10.97 55,234 USD
2022-04-28 2022-04-26 S Sale

Isern Brian M.

possible member of 10% group

Major owner
240 -0.0%
11.90
2,856 USD 		240 -0.0% 11.90 2,856 USD
2022-04-28 2022-04-26 S Sale

Isern Brian M.

possible member of 10% group

Major owner
377 -0.0%
11.90
4,486 USD 		377 -0.0% 11.90 4,486 USD
2022-04-28 2022-04-26 S Sale

Isern Brian M.

possible member of 10% group

Major owner
109 -0.0%
11.90
1,297 USD 		109 -0.0% 11.90 1,297 USD
2021-12-21 2021-12-20 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
7,500 -7.0%
8.54
64,050 USD 		7,500 -7.0% 8.54 64,050 USD
2021-12-20 2021-12-16 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
931 -0.9%
8.38
7,802 USD 		931 -0.9% 8.38 7,802 USD
2021-12-17 2021-12-15 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
2,550 -2.3%
8.01
20,426 USD 		2,550 -2.3% 8.01 20,426 USD
2021-12-10 2021-12-08 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
500 -0.5%
8.00
4,000 USD 		500 -0.5% 8.00 4,000 USD
2021-12-10 2021-12-08 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
8,000 -2.1%
7.84
62,720 USD 		8,000 -2.1% 7.84 62,720 USD
2021-12-09 2021-12-07 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
15,722 -12.5%
8.03
126,248 USD 		15,722 -12.5% 8.03 126,248 USD
2021-12-03 2021-12-01 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
1,600 -1.3%
8.02
12,832 USD 		1,600 -1.3% 8.02 12,832 USD
2021-11-22 2021-11-18 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
800 -0.6%
7.72
6,176 USD 		800 -0.6% 7.72 6,176 USD
2021-11-19 2021-11-17 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
10,297 -7.4%
7.90
81,346 USD 		10,297 -7.4% 7.90 81,346 USD
2021-11-17 2021-11-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
126,000 -25.1%
6.02
758,520 USD 		126,000 -25.1% 6.02 758,520 USD
2021-10-08 2021-10-06 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.5%
4.22
21,100 USD 		5,000 -3.5% 4.22 21,100 USD
2021-09-14 2021-09-10 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.4%
4.23
21,150 USD 		5,000 -3.4% 4.23 21,150 USD
2021-06-10 2021-06-08 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.4%
4.78
23,900 USD 		5,000 -3.4% 4.78 23,900 USD
2021-05-27 2021-05-25 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.3%
4.56
22,800 USD 		5,000 -3.3% 4.56 22,800 USD
2021-04-21 2021-04-19 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.2%
4.54
22,700 USD 		5,000 -3.2% 4.54 22,700 USD
2021-03-12 2021-03-10 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.1%
4.79
23,950 USD 		5,000 -3.1% 4.79 23,950 USD
2021-02-26 2021-02-24 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
100 -0.1%
8.01
801 USD 		100 -0.1% 8.01 801 USD
2021-02-09 2021-02-08 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
8,000 -1.6%
7.26
58,080 USD 		8,000 -1.6% 7.26 58,080 USD
2021-02-04 2021-02-03 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -3.0%
6.91
34,550 USD 		5,000 -3.0% 6.91 34,550 USD
2021-01-27 2021-01-26 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
5,000 -2.9%
7.06
35,300 USD 		5,000 -2.9% 7.06 35,300 USD
2021-01-15 2021-01-14 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
1,655 -0.3%
7.18
11,883 USD 		1,655 -0.3% 7.18 11,883 USD
2021-01-15 2021-01-13 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
15,035 -2.9%
7.41
111,409 USD 		15,035 -2.9% 7.41 111,409 USD
2021-01-13 2021-01-12 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
9,821 -1.8%
7.65
75,131 USD 		9,821 -1.8% 7.65 75,131 USD
2021-01-12 2021-01-11 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
21,489 -3.9%
7.49
160,953 USD 		21,489 -3.9% 7.49 160,953 USD
2020-12-15 2020-12-14 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
50,000 -22.5%
7.90
395,000 USD 		50,000 -22.5% 7.90 395,000 USD
2020-12-23 2020-12-11 B Purchase

McKague Robert

EVP, General Counsel

Officer
10,000 +inf%
7.62
76,200 USD 		10,000 +inf% 7.62 76,200 USD
2020-12-10 2020-12-10 B Purchase

Parker Geoffrey M.

CFO and EVP

Officer
15,000 +60.0%
6.78
101,700 USD 		15,000 +60.0% 6.78 101,700 USD
2020-07-16 2020-07-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -13.6%
26.33
105,320 USD 		4,000 -13.6% 26.33 105,320 USD
2020-07-02 2020-07-01 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -0.7%
27.15
108,600 USD 		4,000 -0.7% 27.15 108,600 USD
2020-06-16 2020-06-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,100 -6.7%
26.20
55,020 USD 		2,100 -6.7% 26.20 55,020 USD
2020-06-16 2020-06-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
1,900 -5.7%
25.71
48,849 USD 		1,900 -5.7% 25.71 48,849 USD
2020-06-03 2020-06-01 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -0.7%
26.23
104,920 USD 		4,000 -0.7% 26.23 104,920 USD
2020-05-19 2020-05-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,000 -5.7%
31.87
63,740 USD 		2,000 -5.7% 31.87 63,740 USD
2020-05-19 2020-05-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,000 -5.4%
31.24
62,480 USD 		2,000 -5.4% 31.24 62,480 USD
2020-05-12 2020-05-12 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and EVP

Officer
1,439 +1.5%
31.66
45,559 USD 		1,439 +1.5% 31.66 45,559 USD
2020-05-12 2020-05-12 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and EVP

Officer
1,303 +1.4%
30.09
39,207 USD 		1,303 +1.4% 30.09 39,207 USD
2020-05-12 2020-05-11 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and EVP

Officer
19,854 +27.4%
30.36
602,767 USD 		19,854 +27.4% 30.36 602,767 USD
2020-05-12 2020-05-11 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and EVP

Officer
12,404 +20.7%
29.48
365,670 USD 		12,404 +20.7% 29.48 365,670 USD
2020-05-12 2020-05-08 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
1,437 -84.9%
31.98
45,955 USD 		1,437 -84.9% 31.98 45,955 USD
2020-05-12 2020-05-08 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
523 -67.2%
31.98
16,726 USD 		523 -67.2% 31.98 16,726 USD
2020-05-12 2020-05-08 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
830 -76.5%
31.98
26,543 USD 		830 -76.5% 31.98 26,543 USD
2020-05-12 2020-05-08 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
210 -45.2%
31.98
6,716 USD 		210 -45.2% 31.98 6,716 USD
2020-05-07 2020-05-05 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
452 -63.9%
30.31
13,700 USD 		452 -63.9% 30.31 13,700 USD
2020-05-07 2020-05-05 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
798 -75.8%
30.05
23,980 USD 		798 -75.8% 30.05 23,980 USD
2020-05-04 2020-05-01 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
100 -0.0%
29.51
2,951 USD 		100 -0.0% 29.51 2,951 USD
2020-05-04 2020-05-01 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
850 -0.2%
28.86
24,531 USD 		850 -0.2% 28.86 24,531 USD
2020-05-04 2020-05-01 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
3,050 -0.5%
27.68
84,424 USD 		3,050 -0.5% 27.68 84,424 USD
2020-04-30 2020-04-29 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
523 -67.2%
31.98
16,726 USD 		523 -67.2% 31.98 16,726 USD
2020-04-30 2020-04-29 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
523 -67.2%
31.98
16,726 USD 		523 -67.2% 31.98 16,726 USD
2020-04-30 2020-04-29 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
1,744 -87.2%
31.98
55,773 USD 		1,744 -87.2% 31.98 55,773 USD
2020-04-30 2020-04-29 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
210 -45.2%
31.98
6,716 USD 		210 -45.2% 31.98 6,716 USD
2020-04-30 2020-04-28 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
1,250 -83.1%
29.98
37,475 USD 		1,250 -83.1% 29.98 37,475 USD
2020-04-16 2020-04-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
100 -0.3%
27.97
2,797 USD 		100 -0.3% 27.97 2,797 USD
2020-04-16 2020-04-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
3,900 -9.4%
27.46
107,094 USD 		3,900 -9.4% 27.46 107,094 USD
2020-04-08 2020-04-06 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -0.7%
24.22
96,880 USD 		4,000 -0.7% 24.22 96,880 USD
2020-03-18 2020-03-16 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -8.8%
23.91
95,640 USD 		4,000 -8.8% 23.91 95,640 USD
2020-03-11 2020-03-10 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and EVP

Officer
5,000 +10.0%
29.46
147,300 USD 		5,000 +10.0% 29.46 147,300 USD
2020-03-04 2020-03-02 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -0.7%
31.53
126,120 USD 		4,000 -0.7% 31.53 126,120 USD
2020-03-04 2020-03-02 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
523 -67.2%
31.98
16,726 USD 		523 -67.2% 31.98 16,726 USD
2020-03-04 2020-03-02 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
523 -67.2%
31.98
16,726 USD 		523 -67.2% 31.98 16,726 USD
2020-03-04 2020-03-02 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
2,994 -92.2%
31.78
95,149 USD 		2,994 -92.2% 31.78 95,149 USD
2020-03-04 2020-03-02 PS Planned sale

Otto Dawn Parsell

EVP, Clinical Development

Officer
210 -45.2%
31.98
6,716 USD 		210 -45.2% 31.98 6,716 USD
2020-03-04 2020-03-02 PS Planned sale

HEJLEK EDWARD J

EVP, General Counsel & Secy.

Officer
200 -1.0%
32.23
6,446 USD 		200 -1.0% 32.23 6,446 USD
2020-03-04 2020-03-02 PS Planned sale

HEJLEK EDWARD J

EVP, General Counsel & Secy.

Officer
9,800 -33.8%
31.65
310,170 USD 		9,800 -33.8% 31.65 310,170 USD
2020-02-20 2020-02-18 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -8.1%
36.10
144,400 USD 		4,000 -8.1% 36.10 144,400 USD
2020-02-06 2020-02-05 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP

Officer
500 -3.3%
38.91
19,455 USD 		500 -3.3% 38.91 19,455 USD